Clinical Biochemistry 3 Flashcards
Functions of the liver in synthesis.
Protein synthesis.
- albumin
- globulin
– positive acute phase proteins
– clotting factors
Glucose synthesis
Cholesterol synthesis
Liver function in detoxification.
Encephalopathic toxins
- Ammonia > urea.
Portal contaminants
- e.g. translocated bacteria.
Bilirubin
Bile acids
Enterically-absorbed drugs.
Non-specific and vague clinical signs of liver disease.
Inappetance
V+/D+
Lethargy
Weight loss
PU/PD (multiple mechs).
Specific clinical signs of liver disease.
Icterus (>40).
- Pre- / hepatic / post-hepatic causes possible (e.g. biliary tree obstruction/pancreatic obstruction).
Coagulopathy
Ascites – due to low albumin levels.
Hepatic encephalopathy
Other; rare.
- Markers of liver damage / “stress”.
- Markers of reduced liver function.
- Hepatocellular enzymes (ALT, AST).
Cholestatic enzymes (ALP, GGT). - Hepatic synthetic products (reduced production).
- urea, albumin, cholesterol, clotting times.
Hepatic detoxification products (accumulation).
- specific markers – bile acids (fasted; dynamic); ammonia (unreliable).
- Bilirubin.
- What does hepatocellular damage result in in terms of hepatocellular enzymes?
- Where is ALT located in the cells?
- When is ALT released?
- What species is ALT useful in?
- In what spp is ALT not useful in?
- In what part of the cell is AST found?
- Where else is AST found?
- Which out of ALT and AST would be picked as a marker of liver damage in dogs and cats? – WHY?
- What should you do if you see AST increase w/o ALT increase to the same level?
- increased hepatocellular enzymes.
- Cytoplasm.
- Hepatocellular repair.
- Dogs, cats, rabbits.
- Horses, ruminants, pigs.
- Mitochondria.
- Muscle.
- ALT. – ALT more sensitive and specific marker than AST.
But if AST is increased as well, can indicate that the damage is more severe. - Measure CK as could be muscle related rather than liver related.
- Hepatocellular enzyme in horses and cattle.
– Why can this be difficult? - Hepatocellular enzyme in large animals and exotics?
– Where is it found?
– Compare to previous enzyme.
– Downside.
- Sorbitol dehydrogenase (SDH).
– Assay not readily available. - Glutamate dehydrogenase (GLDH).
– Many tissues, primary hepatocellular (mitochondrial) origin.
– More stable.
– Less specific for the liver itself as found in many tissues.
- Primary liver disease causes.
- Secondary / reactive liver disease causes.
- Hepatic inflammation, infections, trauma, neoplasia, vacuolar hepatopathy.
Toxins (incl. drugs) – xylitol, alfatoxins, phenobarbitone, methimazole, antifungals, azathioprine. - Due to inflammatory / metabolic process elsewhere in the body.
Commonly seen with e.g. dental disease, GI disease, endocrinopathies (DM, hyperthyroidism, hyperadrenocorticism).
Often mild unless concurrent vacuolar hepatopathy.
- What does an increase in cholestatic enzymes indicate?
- What is ALP/ALKP? – what about in dogs?
- Why is ALP/ALKP seen to be increased during growth?
- What is GGT in dogs?
- In what spp are GGT levels high in colostrum?
– What is it therefore a good marker for? - Why is GGT better marker in equines/cattle than ALP?
- Impaired biliary flow.
- Cholestatic isoenzyme. – steroid isoenzyme.
- It is a bone isoenzyme.
- Steroid isoenzyme.
- Cattle, sheep, dogs.
– Colostrum ingestion in calves. - More sensitive.
- Cholestatic causes of cholestatic enzyme activity increases.
- Non-cholestatic causes of cholestatic enzyme activity increases.
- Primary biliary tree disease – infectious, inflammatory, metabolic (gall bladder, musoceoles, choleliths), toxic (incl. drugs), neoplastic.
- Endocrinopathies/metabolic > vacuolar hepatopathy.
- Hyperadrenocorticism, DM, hepatic lipidosis (ALP).
Steroid induced in dogs.
- Exogenous (iatrogenic) vs endogenous (hyperadrenocorticism).
- NB. phenobarbitone may also cause enzyme induction (ALP, GGT).
Bone induced (ALP) – growth (physiologic), osteolysis (bone cancer).
Evidence of cholestasis.
When mild, evidence only of cholestatic enzyme activity increases.
As progresses, serum accumulation of other substances typically excreted in the bile.
- cholesterol
- bile acids
- bilirubin (bile pigment).
Hepatic enzyme activity interpretation.
Magnitude of increase indicates extent of damage expressed in terms of magnitude of increase above reference interval, not absolute number.
- Mild = ~2-3x
- Moderate = ~ 4-5x
- Marked = >10x
- Hepatocellular vs cholestatic – interrelated.
– Primarily cholestatic = secondary hepatic damage.
– Primarily hepatocellular = secondary cholestasis.
- Half-life influences significance.
– SDH short (12-24hrs) in horses.
– All short (6hrs) in cats.
– Dogs nearer 3 days.
More fussed about liver enzyme changes in cats more than in dogs.
Markers of liver dysfunction.
Liver has large functional reserve.
- May have considerate liver damage W/O dysfunction.
Non-specific – Decreased albumin, urea, cholesterol, glucose.
Specific – increased bilirubin (pre-, hepatic, post-). Hyperbilirubinaemia (<10 micromol/L) vs visible jaundice / icterus (>40micromol/L).
– Increased bile acids.
– Increased ammonia (failure of detoxification).
Bilirubin metabolism.
Bilirubin synthesised from haemoproteins.
Breakdown of red cells in macrophages (in liver / spleen / bone marrow).
Release of bilirubin due to breakdown.
Bilirubin binds to albumin and goes to the liver hepatocytes..
Bilirubin conjugated in the liver hepatocytes.
Bilirubin excreted into the bile to be transported in biliary system to the intestine.
Becomes urobilinogen and either is excreted in faeces as stercobilin or is reabsorbed back to the hepatocytes or excreted in the urine.
more common to see bilirubin in dog urine than in cat urine.
1.Prehepatic hyperbilirubinaemia cause?
2. Hepatic hyperbilirubinaemia cause?
3. Post-hepatic hyperbilirubinaemia cause?
- Excessive production of bilirubin through haemolysis.
- Significant loss of liver function or obstruction by liver swelling.
- Obstructive processes (w/ increases in ALP in particular).